Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Charles Schulz

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
The Journal of Clinical Psychiatry|February 4, 2003
Clinical use of quetiapine in disease states other than schizophreniaAdityanjee, S Charles Schulz
The Journal of Clinical Psychiatry|February 27, 2016
Behavioral and emerging pharmacologic treatment options for cognitive impairment in schizophreniaSophia Vinogradov, S Charles Schulz
Schizophrenia Bulletin|December 1, 2007
Editorial: research progress in early-onset schizophreniaSanjiv Kumra, S Charles Schulz
The Journal of Clinical Psychiatry|February 27, 2016
Assessing cognitive impairment in patients with schizophreniaS Charles Schulz, Aimee Murray
Schizophrenia Research|July 9, 2011
The legacy of "just the facts"Angus W MacDonald, S Charles Schulz
The American Journal of Psychiatry|August 4, 2015
Clinical Trials for Treatment of Borderline Personality DisorderS Charles Schulz, Donald W Black
European Heart Journal|March 25, 2015
Vital exhaustion: ready for prime time?Russell V Luepker, S Charles Schulz
Schizophrenia Bulletin|March 31, 2009
What we know: findings that every theory of schizophrenia should explainAngus W MacDonald, S Charles Schulz
Schizophrenia Research|May 27, 2003
The efficacy of quetiapine vs haloperidol and placebo: a meta-analytic study of efficacyS Charles Schulz, Ruth Thomson, Martin Brecher
The American Journal of Psychiatry|March 4, 2006
The schizophrenia prodromeTonya White, Afshan Anjum, S Charles Schulz
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
The Journal of Clinical Psychiatry|February 4, 2003
Clinical use of quetiapine in disease states other than schizophreniaAdityanjee, S Charles Schulz
The Journal of Clinical Psychiatry|February 27, 2016
Behavioral and emerging pharmacologic treatment options for cognitive impairment in schizophreniaSophia Vinogradov, S Charles Schulz
Schizophrenia Bulletin|December 1, 2007
Editorial: research progress in early-onset schizophreniaSanjiv Kumra, S Charles Schulz
The Journal of Clinical Psychiatry|February 27, 2016
Assessing cognitive impairment in patients with schizophreniaS Charles Schulz, Aimee Murray
Schizophrenia Research|July 9, 2011
The legacy of "just the facts"Angus W MacDonald, S Charles Schulz
The American Journal of Psychiatry|August 4, 2015
Clinical Trials for Treatment of Borderline Personality DisorderS Charles Schulz, Donald W Black
European Heart Journal|March 25, 2015
Vital exhaustion: ready for prime time?Russell V Luepker, S Charles Schulz
Schizophrenia Bulletin|March 31, 2009
What we know: findings that every theory of schizophrenia should explainAngus W MacDonald, S Charles Schulz
Schizophrenia Research|May 27, 2003
The efficacy of quetiapine vs haloperidol and placebo: a meta-analytic study of efficacyS Charles Schulz, Ruth Thomson, Martin Brecher
The American Journal of Psychiatry|March 4, 2006
The schizophrenia prodromeTonya White, Afshan Anjum, S Charles Schulz
Pageof 7